Specialty
Endocrinology & Diabetes Technology devices
Last checked: Nov 19, 2026Source: openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
330
510(k), De Novo and PMA
Decisions, last 36 months
88
Recruiting device trials
42
Industry sponsored
Adverse event reports
1,393,469
Received Nov 1, 2025 to Nov 19, 2026
Part of
Latest FDA decisions
The 8 newest. A specialty is the FDA review panel, or a list of product codes for a narrower view.
K260738 · Decided Oct 30, 2026 · 238 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
K261293 · Decided Oct 23, 2026 · 186 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
- Mint ACE Pump510(k)
K263422 · Decided Oct 21, 2026 · 26 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
- twiist Loop Algorithm510(k)
Deka Research and Development Corp.
K262576 · Decided Oct 15, 2026 · 80 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
Vivachek Biotech (Hangzhou) Co., Ltd.
K260687 · Decided Oct 9, 2026 · 220 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
K260689 · Decided Oct 2, 2026 · 213 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
K262599 · Decided Sep 18, 2026 · 53 days after receipt
Device type: Glucose Range Monitoring System (SFU) · Laboratory Medicine & Pathology
- iOS CamAPS FX510(k)
K261896 · Decided Sep 16, 2026 · 100 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
FDA decisions per month
Last 36 months, by decision date and pathway.
- 510(k)
- De Novo
- PMA
View as table
| Month | 510(k) | De Novo | PMA |
|---|---|---|---|
| Dec 23 | 3 | 0 | 0 |
| Jan 24 | 2 | 0 | 0 |
| Feb 24 | 3 | 0 | 0 |
| Mar 24 | 4 | 0 | 0 |
| Apr 24 | 3 | 1 | 0 |
| May 24 | 4 | 0 | 0 |
| Jun 24 | 2 | 0 | 0 |
| Jul 24 | 2 | 0 | 1 |
| Aug 24 | 4 | 0 | 0 |
| Sep 24 | 2 | 0 | 0 |
| Oct 24 | 1 | 0 | 0 |
| Nov 24 | 3 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 |
| Feb 25 | 1 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 |
| Apr 25 | 2 | 0 | 1 |
| May 25 | 1 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 |
| Jul 25 | 1 | 0 | 0 |
| Aug 25 | 1 | 0 | 2 |
| Sep 25 | 2 | 1 | 0 |
| Oct 25 | 1 | 0 | 0 |
| Nov 25 | 2 | 0 | 0 |
| Dec 25 | 3 | 0 | 1 |
| Jan 26 | 2 | 0 | 0 |
| Feb 26 | 2 | 0 | 0 |
| Mar 26 | 1 | 0 | 0 |
| Apr 26 | 4 | 0 | 0 |
| May 26 | 1 | 0 | 0 |
| Jun 26 | 5 | 0 | 0 |
| Jul 26 | 2 | 0 | 0 |
| Aug 26 | 2 | 1 | 0 |
| Sep 26 | 6 | 0 | 0 |
| Oct 26 | 6 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 |
Recruiting device trials
Industry-sponsored device trials that are recruiting now, most recently updated first.
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsPivotal-lookingRecruiting
Cleerly, Inc.Not on our public-company list
NCT06112418 · 7,500 participants (planned) · Start Mar 6, 2024 · Primary completion Mar 5, 2029
Device: The Cleerly CAD Staging System · For: Diabetes Mellitus, Type 2; PreDiabetes; Metabolic Syndrome
Sites: Chandler, Arizona; Scottsdale, Arizona; Sun City, Arizona · 125 sites in all
- Silica-Based Wound Treatment (Curi01) Plus Standard Care Versus Standard Care Alone for Chronic Diabetic Foot WoundsPivotal-lookingRecruiting
Cutempa Medical AGNot on our public-company list
NCT07937215 · 280 participants (planned) · Start Aug 20, 2026 · Primary completion Feb 2028
Device: Curi01 · For: Diabetic Foot Disease; Foot Ulcer Due to Type 1 Diabetes Mellitus; Foot Ulcer Due to Type 2 Diabetes Mellitus
Sites: Bad Mergentheim, Germany; Berlin, Germany; Bremerhaven, Germany · 13 sites in all
Medtronic MiniMed, Inc.Public (MDT)
NCT07864168 · 1,500 participants (planned) · Start Oct 5, 2026 · Primary completion Dec 2027
Device: Next Generation Extended Wear Sensors · For: Type 1 Diabetes; Type 2 Diabetes
Sites: Chula Vista, California; Escondido, California; Palo Alto, California · 19 sites in all
Bionime CorporationNot on our public-company list
NCT07889388 · 104 participants (planned) · Start Jun 9, 2026 · Primary completion Mar 2027
Device: RIGHTEST iFree 2 Continuous Glucose Monitoring System · For: Diabetes Mellitus, Type 1 Diabetes; Diabetes Mellitus, Type 2; Diabetes, Gestational
Sites: Ulm, Germany
SolsiusNot on our public-company list
NCT07910721 · 60 participants (planned) · Start Mar 10, 2026 · Primary completion Apr 10, 2027
Device: Solsius SelfCare · For: Diabetic Foot Disease; Diabetic Foot Infection; Diabetic Foot Infections and 3 more
Sites: Lille, France; Montpellier, France · 3 sites in all
- Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes MellitusPivotal-lookingRecruiting
Hoffmann-La RocheNot on our public-company list
NCT06704672 · 270 participants (planned) · Start Apr 14, 2025 · Primary completion Nov 15, 2026
Device: Accu-Chek SmartGuide CGM Solution; Accu-Chek SmartGuide Sensor and Blinded Apps and 1 more · For: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
Sites: Gdansk, Poland; Krakow, Poland; Kraśnik, Poland · 20 sites in all
How new technology gets paid for
Recent Medicare coverage decisions that touch this specialty.
Reports received
1,393,469
Received Nov 1, 2025 to Nov 19, 2026. Includes 809 of another or unstated type.
Malfunction reports
1,298,531
93% of reports
Injury reports
93,660
6.7% of reports
Death reports
469
0.0% of reports
Adverse event reports received per month
By the date FDA received each report. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Nov 25 | 63,571 | 5,617 | 31 | 0 |
| Dec 25 | 78,968 | 7,909 | 40 | 1 |
| Jan 26 | 127,346 | 7,488 | 42 | 5 |
| Feb 26 | 69,524 | 7,374 | 38 | 0 |
| Mar 26 | 72,989 | 7,513 | 35 | 2 |
| Apr 26 | 98,598 | 8,677 | 42 | 0 |
| May 26 | 98,541 | 7,868 | 28 | 1 |
| Jun 26 | 111,605 | 8,384 | 39 | 1 |
| Jul 26 | 107,964 | 8,377 | 55 | 101 |
| Aug 26 | 200,470 | 8,228 | 51 | 180 |
| Sep 26 | 184,566 | 8,418 | 40 | 207 |
| Oct 26 | 84,389 | 7,807 | 28 | 311 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types with the most reports
Widely used device types get more reports. This is not a ranking of safety.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0316-2027 · Started Sep 23, 2026 · Posted by FDA Oct 30, 2026
Reason given: Tandem Diabetes Care, Inc. ( Tandem ) has identified that certain Tandem Mobi insulin pumps may generate false-positive occlusion alarms when no actual insulin flow obstruction is present. Investigation determined that increased friction within the drive module can reduce available motor power and, under certain...
Cause as FDA categorized it: Process change control · Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG)
- CareLink Clinic, REF: MMT-7350Open, Classified
Z-0203-2027 · Started Sep 11, 2026 · Posted by FDA Oct 21, 2026
Reason given: CareLink Clinic software version 4.4A includes a software defect in the Settings Calculator feature in which the calculation logic fails to use custom values entered by healthcare professionals (HCPs) for Total Daily Dose (TDD) or Long-acting insulin when calculating the Carb Ratio, Insulin Sensitivity Factor (ISF),...
Cause as FDA categorized it: Software design · Device type: Continuous Glucose Monitor Retrospective Data Analysis Software (PHV)
Z-0088-2027 · Started Aug 20, 2026 · Posted by FDA Oct 5, 2026
Reason given: Some MiniMed Flex insulin pumps were released with missing (i.e., devices with no result or abort test results are presumed to have failed) or failed verification test results in one or more of 9 functional tests. The unverified/failed pumps released to users potentially have one or more of the following issues:...
Cause as FDA categorized it: Under Investigation by firm · Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG)
Z-3128-2026 · Started Jul 29, 2026 · Posted by FDA Sep 11, 2026
Reason given: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the...
Cause as FDA categorized it: Software design · Device type: Prescription Use Blood Glucose Meter For Near-Patient Testing (PZI)
Z-3129-2026 · Started Jul 29, 2026 · Posted by FDA Sep 11, 2026
Reason given: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the...
Cause as FDA categorized it: Software design · Device type: Prescription Use Blood Glucose Meter For Near-Patient Testing (PZI)
Z-3130-2026 · Started Jul 29, 2026 · Posted by FDA Sep 11, 2026
Reason given: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the...
Cause as FDA categorized it: Software design · Device type: Prescription Use Blood Glucose Meter For Near-Patient Testing (PZI)
Z-3131-2026 · Started Jul 29, 2026 · Posted by FDA Sep 11, 2026
Reason given: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the...
Cause as FDA categorized it: Software design · Device type: Prescription Use Blood Glucose Meter For Near-Patient Testing (PZI)
Z-3132-2026 · Started Jul 29, 2026 · Posted by FDA Sep 11, 2026
Reason given: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the...
Cause as FDA categorized it: Software design · Device type: Prescription Use Blood Glucose Meter For Near-Patient Testing (PZI)
Showing the 8 newest of 465 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.